subject: Cystic Fibrosis - Drug Pipeline Analysis And Market Forecasts To 2015---aarkstore Enterprise Market [print this page] Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015
Summary
The industry analysis specialists new report, Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global cystic fibrosis (CF) market. The report identifies the key trends shaping and driving the global CF market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global CF sector.This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The scope of the report includes:
* Annualized global cystic fibrosis market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
* Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
* Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include antibiotics and anti-infective agents, Ion transport modulators, anti-inflammatory agents, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, Nutritional supplements and Pancreatic Enzyme Replacement Therapy (PERT) classes of drugs.
* Analysis of the current and future market competition in the global CF market. Key market players covered are Cystic Fibrosis Foundation Therapeutics, Inc (CFFT), Pharmaxis, Gilead Sciences, Vertex Pharma, AstraZeneca and Pari Pharma.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with cystic fibrosis.
